Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard L Parnes

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 18, 2014
Phase III prostate cancer chemoprevention trialsHoward L Parnes, Otis W Brawley, Lori M Minasian, et al.
The Journal of Urology|January 10, 2004
Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolioHoward L Parnes, Margaret G House, Jacob Kagan, et al.
Biostatistics (Oxford, England)|February 23, 2010
Transparency and reproducibility in data analysis: the Prostate Cancer Prevention TrialStuart G Baker, Amy K Darke, Paul Pinsky, et al.
Current Opinion in Oncology|March 28, 2012
Active surveillance for prostate cancer: past, present and futureEric A Singer, Aradhana Kaushal, Baris Turkbey, et al.
Urology|May 6, 2008
Does the level of prostate cancer risk affect cancer prevention with finasteride?Ian M Thompson, Catherine M Tangen, Howard L Parnes, et al.
Cancer Research|September 27, 2007
Meeting Report: Fifth Annual AACR Frontiers in Cancer Prevention ResearchAshraful Hoque, Howard L Parnes, Michael E Stefanek, et al.
The Prostate|January 1, 2008
Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatmentYoonJu Song, Catherine Tangen, Phyllis Goodman, et al.
Cancer Epidemiology|September 25, 2012
Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialPaul F Pinsky, Amanda Black, Howard L Parnes, et al.
The Journal of Urology|April 18, 2007
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detectionIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
JAMA Dermatology|November 27, 2014
Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinibRena C Zuo, Andrea B Apolo, John J DiGiovanna, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 18, 2014
Phase III prostate cancer chemoprevention trialsHoward L Parnes, Otis W Brawley, Lori M Minasian, et al.
The Journal of Urology|January 10, 2004
Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolioHoward L Parnes, Margaret G House, Jacob Kagan, et al.
Biostatistics (Oxford, England)|February 23, 2010
Transparency and reproducibility in data analysis: the Prostate Cancer Prevention TrialStuart G Baker, Amy K Darke, Paul Pinsky, et al.
Current Opinion in Oncology|March 28, 2012
Active surveillance for prostate cancer: past, present and futureEric A Singer, Aradhana Kaushal, Baris Turkbey, et al.
Urology|May 6, 2008
Does the level of prostate cancer risk affect cancer prevention with finasteride?Ian M Thompson, Catherine M Tangen, Howard L Parnes, et al.
Cancer Research|September 27, 2007
Meeting Report: Fifth Annual AACR Frontiers in Cancer Prevention ResearchAshraful Hoque, Howard L Parnes, Michael E Stefanek, et al.
The Prostate|January 1, 2008
Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatmentYoonJu Song, Catherine Tangen, Phyllis Goodman, et al.
Cancer Epidemiology|September 25, 2012
Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialPaul F Pinsky, Amanda Black, Howard L Parnes, et al.
The Journal of Urology|April 18, 2007
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detectionIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
JAMA Dermatology|November 27, 2014
Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinibRena C Zuo, Andrea B Apolo, John J DiGiovanna, et al.
Pageof 11